beta-D-Galp-(1->2)-alpha-D-Galp-(1->3)-beta-L-Rhap-(1->4)-beta-D-GlcpO[CH2]5NH2

Term ID

CHEBI:140508

Synonyms

5-aminopentyl beta-D-galactopyranosyl-(1->2)-alpha-D-galactopyranosyl-(1->3)-6-deoxy-beta-L-mannopyranosyl-(1->4)-beta-D-glucopyranoside
5-aminopentyl beta-D-galactopyranosyl-(1->2)-alpha-D-galactopyranosyl-(1->3)-beta-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranoside
5-aminopentyl beta-D-galactosyl-(1->2)-alpha-D-galactosyl-(1->3)-beta-L-rhamnosyl-(1->4)-beta-D-glucoside
beta-D-Gal-(1->2)-alpha-D-Gal-(1->3)-beta-L-Rha-(1->4)-beta-D-GlcO[CH2]5NH2
Galbeta1-2Galalpha1-3Rhabeta1-4GlcbetaO[CH2]5NH2

Definition

A linear tetrasaccharide derivative consisting of beta-D-galactose, alpha-D-galactose, beta-L-rhamnose and beta-D-glucose residues linked sequentially (1->2), (1->3) and (1->4), with the glucose residue linked glycosidically to a 5-aminopentyl group.

References

PMID:29333751

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycoside tetrasaccharide derivative

glycoside tetrasaccharide derivative Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-Galp-(1->2)-alpha-D-Galp-(1->3)-beta-L-Rhap-(1->4)-beta-D-GlcpO[CH2]5NH2

Phenotype where environments contain beta-D-Galp-(1->2)-alpha-D-Galp-(1->3)-beta-L-Rhap-(1->4)-beta-D-GlcpO[CH2]5NH2

Phenotype modified by environments containing beta-D-Galp-(1->2)-alpha-D-Galp-(1->3)-beta-L-Rhap-(1->4)-beta-D-GlcpO[CH2]5NH2

Human Disease Model